Clinical Trials
Showing trials with last updates posted in 2025.
160
Participants
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-07-25
Completion:
2028-09-30
Conditions
Brain Concussion
Brain Trauma
Attention Concentration Difficulty
Brain Injuries
Brain Injuries, Traumatic
Neurocognitive Dysfunction
Attention Impaired
Memory Impairment
Mild Traumatic Brain Injury
Mild Cognitive Impairment
Post Concussive Symptoms
Interventions
COMBINATION_PRODUCT
No Results Yet
55
Participants
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-05-29
Completion:
2030-01-31
Conditions
Pediatric
Symptomatic Obstructive Hypertrophic Cardiomyopathy
Interventions
DRUG
No Results Yet
612
Participants
The M-Well Inpatient Whole Health Bundle
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-06-12
Completion:
2025-10-22
Conditions
Patient Satisfaction
Interventions
BEHAVIORAL
No Results Yet
46
Participants
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2025-04-25
Completion:
2026-02-28
Conditions
Electronic Nicotine Delivery Systems
Tobacco Products
Cigarette Smoking
Interventions
BEHAVIORAL
No Results Yet
90
Participants
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-08-16
Completion:
2029-03-31
Conditions
B-cell Acute Lymphoblastic Leukemia
Diffuse Large B-cell Lymphoma
Burkitt Lymphoma
Neuroblastoma
Ewing Sarcoma
Interventions
BIOLOGICAL
No Results Yet
112
Participants
Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-05-15
Completion:
2026-05-30
Conditions
Indolent B-Cell Non-Hodgkin Lymphoma
Recurrent Indolent B-Cell Non-Hodgkin Lymphoma
Refractory Indolent B-Cell Non-Hodgkin Lymphoma
Recurrent Indolent Non-Hodgkin Lymphoma
Refractory Indolent Non-Hodgkin Lymphoma
Interventions
PROCEDURE
RADIATION
OTHER
No Results Yet
43
Participants
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-06-10
Completion:
2030-06-30
Conditions
Alzheimer's Disease
Dementia
Alzheimer's Disease, Familial
Interventions
DRUG
No Results Yet
650
Participants
Military Health and Nutrition Examination Study
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-12
Start Date:
2024-08-24
Completion:
2026-12-01
Conditions
Hypertension
Type 2 Diabetes
Dyslipidemias
Cardiovascular Diseases
No Results Yet
150
Participants
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-11-19
Completion:
2027-06-30
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Interventions
DRUG
No Results Yet
[Trial of device that is not approved or cleared by the U.S. FDA]
Last Updated:
2025-11-12
No Results Yet
50
Participants
PICNIC Study - PatIent Centered aNtIbiotic Courses in Children With Medical Complexity
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-08-20
Completion:
2026-06-01
Conditions
Pneumonia
Interventions
OTHER
No Results Yet
32
Participants
Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2026-01-05
Completion:
2027-02-28
Conditions
Stress
Interventions
DRUG
PROCEDURE
No Results Yet
120
Participants
GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2025-04-29
Completion:
2026-05-31
Conditions
Celiac Disease in Children
Nutrition Disorder, Child
Interventions
OTHER
No Results Yet
220
Participants
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-05-20
Completion:
2029-01-15
Conditions
Prostatic Neoplasms, Castration-Resistant
Interventions
DRUG
No Results Yet
2
Participants
ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-10-02
Completion:
2025-04-28
Conditions
Relapsed and/or Refractory Multiple Myeloma
Interventions
DRUG
No Results Yet
33
Participants
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-07-11
Completion:
2026-12-31
Conditions
Gynecologic Cancer
Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cavity Cancer
Interventions
DRUG
No Results Yet
28
Participants
Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-11-02
Completion:
2025-10-01
Conditions
Continuous Glucose Monitoring
Interventions
DEVICE
No Results Yet
322
Participants
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-09-05
Completion:
2025-11-14
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG
No Results Yet
393
Participants
A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-05-10
Completion:
2026-03-31
Conditions
Moderate Plaque Psoriasis
Interventions
DRUG
No Results Yet
14
Participants
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2026-03-01
Completion:
2026-12-31
Conditions
Preeclampsia
Interventions
DRUG
No Results Yet
184
Participants
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-11-08
Completion:
2028-07-15
Conditions
Progressive Glioblastoma
Recurrent Glioblastoma
Interventions
PROCEDURE
DRUG
BIOLOGICAL
No Results Yet
582
Participants
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-06-03
Completion:
2029-09-28
Conditions
Metastatic Breast Cancer
Metastatic Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Interventions
DRUG
No Results Yet
153
Participants
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2025-06-05
Completion:
2028-12-31
Conditions
Acute Leukemia of Ambiguous Lineage
B Acute Lymphoblastic Leukemia
Interventions
DRUG
PROCEDURE
BIOLOGICAL
No Results Yet
147
Participants
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-09-27
Completion:
2025-10-31
Conditions
Acute Myeloid Leukemia
Interventions
DRUG
PROCEDURE
No Results Yet
158
Participants
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-04-04
Completion:
2025-10-01
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG
No Results Yet
45
Participants
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2025-04-08
Completion:
2029-07-25
Conditions
Extensive Stage Lung Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8
Interventions
BIOLOGICAL
PROCEDURE
DRUG
No Results Yet
112
Participants
Single and Multiple Ascending Dose Study and Food Effect Study for AG181
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-02-20
Completion:
2026-03-31
Conditions
Healthy Volunteers
Interventions
DRUG
No Results Yet
224
Participants
Penn Medicine Food Market Study
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-08-01
Completion:
2025-05-01
Conditions
Obesity
Diabetes
Interventions
BEHAVIORAL
No Results Yet
0
Participants
MACE CDS Software Master Enrollment Protocol
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-12
Start Date:
2023-09-14
Completion:
2025-05-31
Conditions
Cardiac Events
Interventions
DEVICE
No Results Yet
12
Participants
ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-09-19
Completion:
2027-12-31
Conditions
Recurrent Oligodendroglioma
Progressive Oligodendroglioma
Interventions
BIOLOGICAL
DRUG
No Results Yet
70
Participants
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-02-06
Completion:
2026-12-31
Conditions
NSCLC
Interventions
DRUG
No Results Yet
10
Participants
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-02-20
Completion:
2026-01-15
Conditions
Acute Lymphoblastic Leukemia
Diffuse Large B Cell Lymphoma
Interventions
BIOLOGICAL
No Results Yet
156
Participants
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-07-31
Completion:
2027-06-30
Conditions
Acute Ischemic Stroke
Interventions
DRUG
No Results Yet
79
Participants
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-08-23
Completion:
2026-06-30
Conditions
Obesity
Healthy Volunteer
Interventions
OTHER
No Results Yet
87
Participants
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-02-20
Completion:
2027-04-10
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
307
Participants
A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-02-06
Completion:
2025-07-29
Conditions
Obesity
Overweight
Interventions
DRUG
No Results Yet
39
Participants
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2023-06-13
Completion:
2024-11-06
Conditions
Metastatic Non-small Cell Lung Cancer
Interventions
BIOLOGICAL
DRUG
195
Participants
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2024-03-25
Completion:
2026-06-30
Conditions
Polycystic Ovary Syndrome
Infertility, Female
Interventions
DEVICE
No Results Yet
66
Participants
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2025-04-01
Completion:
2027-10-01
Conditions
Breast Atypical Hyperplasia
Breast Carcinoma
Breast Ductal Carcinoma In Situ
Breast Lobular Carcinoma In Situ
Interventions
PROCEDURE
DRUG
OTHER
No Results Yet
315
Participants
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-12
Start Date:
2025-03-11
Completion:
2026-11-11
Conditions
Pulmonary Tuberculosis
Interventions
DRUG
No Results Yet
Showing 40 trials per page ยท Total 107726 trials